Clinically relevant depressive symptoms were associated with a greater decline in MMSE score over 7 years compared to those without such symptoms (estimate = -0.17; P < 0.001).
Cohort (n=2,812)
Yes
Does the presence of clinically relevant depressive symptoms increase cognitive decline in older Mexican Americans?
Clinically relevant depressive symptoms are associated with subsequent cognitive decline over 7 years in older Mexican Americans, independent of demographic and health factors.
Effect estimate: Estimate -0.17
p-value: p=<0.001
To examine the association between presence of clinically relevant depressive symptoms (Center for Epidemiologic Studies Depression Scale CES-D score >or= 16) and subsequent cognitive function (Mini-Mental State Examination MMSE) over a 7-year period in older Mexican Americans, a prospective cohort study was performed. Five south-western states contributed data to the Hispanic Established Populations for Epidemiologic Studies of the Elderly. Participants included 2812 noninstitutionalized Mexican Americans aged 65 and older followed from 1993-1994 until 2000-2001. Cognitive change was assessed using the MMSE at baseline and at 2, 5, and 7 years of follow-up. Independent variables were sociodemographics, CES-D >or= 16, medical conditions (hypertension, diabetes, coronary artery disease, and stroke), and activities of daily living (ADL) status. A general linear mixed model was used to estimate cognitive change. There was a cross-sectional association between CES-D >or= 16 and lower MMSE score (estimate = -0.48; standard error SE = 0.15; P < .01), independent of age, gender, education, marital status, time of interview, ADL limitations, vision impairment, and medical conditions. In the fully adjusted longitudinal model, subjects with clinically relevant depressive symptoms had a greater decline in MMSE score over 7 years than those without clinically relevant depressive symptoms (estimate = -0.17; SE = 0.05; P < .001), adjusting for sociodemographics, ADL and medical conditions. Each point increase in the CES-D score was associated with a decline of 0.010 point in MMSE score per year (SE = 0.002; P < 0.0001), adjusting for relevant confounders. Presence of clinically relevant depressive symptoms was associated with subsequent decline in cognitive function over 7 years in older Mexican Americans, independent of demographic and health factors.
Raji et al. (Tue,) conducted a cohort in Depressive symptoms and cognitive decline (n=2,812). Clinically relevant depressive symptoms (CES-D ≥ 16) vs. No clinically relevant depressive symptoms was evaluated on Cognitive change (MMSE score) over 7 years (Estimate -0.17, p=<0.001). Clinically relevant depressive symptoms were associated with a greater decline in MMSE score over 7 years compared to those without such symptoms (estimate = -0.17; P < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: